During the past decade, National University Heart Centre, Singapore conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National University Heart Centre, Singapore" #1 sponsor was "Actelion" with 4 trials, followed by "National University Hospital, Singapore" with 3 trials sponsored, "National University Heart Centre, Singapore" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Carolyn Lam" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National University Heart Centre, Singapore" #1 collaborator was "National University Heart Centre, Singapore" with 3 trials as a collaborator, "Tan Tock Seng Hospital" with 3 trials as a collaborator, "National University of Singapore" with 2 trials as a collaborator, "Ulsan University Hospital" with 2 trials as a collaborator and "ATTRaCT program by A*STAR BMRC Singapore" with 1 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "National University Heart Centre, Singapore" are "Heart Failure" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Acute Coronary Syndrome" (2 trials), "Aortic Valve Stenosis" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "National University Heart Centre, Singapore" in a lesser frequency.

Most popular intervention types in "National University Heart Centre, Singapore" are "Drug" (8 trials), "Device" (5 trials), "Other" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Macitentan" (2 trials), "AZD5718" (1 trials), "Cardiac Magnetic Resonance (CMR)" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "National University Heart Centre, Singapore" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National University Heart Centre, Singapore". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National University Heart Centre, Singapore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National University Heart Centre, Singapore, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".